Pharmbio Korea
VC Fund
Seocho, South Korea
Pharmbio Korea is a VC fund in Seocho focused on Medical and Chemical. Pharmbio Korea Company Ltd is a pharmaceutical company. The Company develops drugs for urinary tract infections, diuresis & relaxes urinary tract spasm, gallstones, and difficult digestion.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Pharmbio Korea invests in
Stages Pharmbio Korea invests in
Countries Pharmbio Korea invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Medical 1 (100%)
- Chemical 1 (100%)
- Venture Capital 1 (100%)
- Product Research 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bong-Kil Nam
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Master Meditech is a venture company that discovers new drugs with protein structure identification and medicinal chemistry. | $7.1M / Series A / Mar 31, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Pharmbio Korea invest in?
Pharmbio Korea invests primarily in Medical, Chemical and Venture Capital startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pharmbio Korea?
Public channels for Pharmbio Korea include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pharmbio Korea?
The team at Pharmbio Korea includes Bong-Kil Nam (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!